Pub Date : 2023-10-20DOI: 10.21608/bmfj.2023.234928.1894
Mohamed Elmaghrabi, Waleed Badawy, Mohammed Eltantawy, Heba Abdelhady, Shawky Elmeleigy
: Background: Acquired Hydrocephalus can develop at birth or in adulthood. It has many etiologies like obstruction by Tumors, inflammatory and infective lesions like meningioencephalitis and cerebral abscess. It may result from Hemorrhage like parenchymal hemorrhage, intra-ventricular hemorrhage, germinal matrix hemorrhage(GMH). GMH is the leading cause of acquired infantile hydrocephalus in preterms. But still the main causes of secondary hydrocephalus in the infantile age groups post-meningetic and post hemorrhagic. Aim: the aim of this study is to evaluate the different prognostic factors affecting the clinical and surgical outcome in cases of secondary hydrocephalus in infants. Methods: This is a prospective study conducted on 30 non-consecutive cases with secondary hydrocephalus who underwent surgery by variable surgical procedures at Benha University Hospital from March 2022 to June 2023. Results: The mean age of the included patients was 11.43 months. The distribution of underlying pathology of studied cases was (Post-meningetic 80%, Post-hemorrhagic 13.3%, Post-tumor 6.7%). Cases were followed up for 6-12 months. There was reported incidence of favorable clinical and surgical outcome of 60 % of cases with no need for any surgical procedure and adverse outcome in 40%. Conclusion: Secondary hydrocephalus in a premature baby, with LBW, especially if admitted to NICU for more than 1 month, with presence of systemic sepsis and CSF infection by G-ve bacilli especially with frequent CSF tapping had the worst outcome. While maturity and normal birth weight without NICU admission, and absence of sepsis with negative CSF culture predicting a favorable clinical and surgical outcome.
{"title":"Prognostic factors affecting the surgical outcome of secondary hydrocephalus in infants","authors":"Mohamed Elmaghrabi, Waleed Badawy, Mohammed Eltantawy, Heba Abdelhady, Shawky Elmeleigy","doi":"10.21608/bmfj.2023.234928.1894","DOIUrl":"https://doi.org/10.21608/bmfj.2023.234928.1894","url":null,"abstract":": Background: Acquired Hydrocephalus can develop at birth or in adulthood. It has many etiologies like obstruction by Tumors, inflammatory and infective lesions like meningioencephalitis and cerebral abscess. It may result from Hemorrhage like parenchymal hemorrhage, intra-ventricular hemorrhage, germinal matrix hemorrhage(GMH). GMH is the leading cause of acquired infantile hydrocephalus in preterms. But still the main causes of secondary hydrocephalus in the infantile age groups post-meningetic and post hemorrhagic. Aim: the aim of this study is to evaluate the different prognostic factors affecting the clinical and surgical outcome in cases of secondary hydrocephalus in infants. Methods: This is a prospective study conducted on 30 non-consecutive cases with secondary hydrocephalus who underwent surgery by variable surgical procedures at Benha University Hospital from March 2022 to June 2023. Results: The mean age of the included patients was 11.43 months. The distribution of underlying pathology of studied cases was (Post-meningetic 80%, Post-hemorrhagic 13.3%, Post-tumor 6.7%). Cases were followed up for 6-12 months. There was reported incidence of favorable clinical and surgical outcome of 60 % of cases with no need for any surgical procedure and adverse outcome in 40%. Conclusion: Secondary hydrocephalus in a premature baby, with LBW, especially if admitted to NICU for more than 1 month, with presence of systemic sepsis and CSF infection by G-ve bacilli especially with frequent CSF tapping had the worst outcome. While maturity and normal birth weight without NICU admission, and absence of sepsis with negative CSF culture predicting a favorable clinical and surgical outcome.","PeriodicalId":8803,"journal":{"name":"Benha Veterinary Medical Journal","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135665228","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-10-14DOI: 10.21608/bmfj.2023.233204.1886
Waleed Tawfik, AMAL AMIN, Mahmoud Fayed, Yousef Abdelzaher
: Background: An intrauterine device (IUD) is a small, often T-shaped birth control device that is inserted into the uterus to prevent pregnancy. IUDs are one form of long-acting reversible birth control (LARC). This study's objective was to compare between post placental insertions of different types of IUD (PPIUD) during cesarean section versus delayed IUD (DIUD) insertion. Methods: This prospective interventional study was conducted on 300 women who delivered via uncomplicated cesarean section and seeking IUD contraception. Patients were divided into two equal groups: PPIUD group: women received post placental insertion of different types of IUD (50 received copper T, 50 received Nova T, and 50 received multiload). DIUD Group: women received delayed insertion of different types of IUD (50 received copper T, 50 received Nova T, and 50 received multiload). Results: At 12 months follow-up there was no statistically significant difference between the 2 groups as regards complications. As regards satisfaction rates, 129 were satisfied with the IUD in the DIUD group, and 118 were satisfied with the IUD in PPIUD, and this difference was not statistically significant (p >0.05). Prevalence of outcomes according to type of device in patients in DIUD group, data was insignificant in all outcomes except bleeding. Conclusions: Post-placental insertion of IUD during a cesarean section appears to be a more effective and convenient method of contraception compared to delayed insertion of an IUD. This study showed that post-placental IUD insertion is associated with lower rates of expulsion, thread visibility and menorrhagia compared to delayed insertion.
{"title":"Post Placental Insertion of Different Types of Intrauterine Device During Cesarean Section versus Delayed Intrauterine Device Insertion in Sharkia Governorate","authors":"Waleed Tawfik, AMAL AMIN, Mahmoud Fayed, Yousef Abdelzaher","doi":"10.21608/bmfj.2023.233204.1886","DOIUrl":"https://doi.org/10.21608/bmfj.2023.233204.1886","url":null,"abstract":": Background: An intrauterine device (IUD) is a small, often T-shaped birth control device that is inserted into the uterus to prevent pregnancy. IUDs are one form of long-acting reversible birth control (LARC). This study's objective was to compare between post placental insertions of different types of IUD (PPIUD) during cesarean section versus delayed IUD (DIUD) insertion. Methods: This prospective interventional study was conducted on 300 women who delivered via uncomplicated cesarean section and seeking IUD contraception. Patients were divided into two equal groups: PPIUD group: women received post placental insertion of different types of IUD (50 received copper T, 50 received Nova T, and 50 received multiload). DIUD Group: women received delayed insertion of different types of IUD (50 received copper T, 50 received Nova T, and 50 received multiload). Results: At 12 months follow-up there was no statistically significant difference between the 2 groups as regards complications. As regards satisfaction rates, 129 were satisfied with the IUD in the DIUD group, and 118 were satisfied with the IUD in PPIUD, and this difference was not statistically significant (p >0.05). Prevalence of outcomes according to type of device in patients in DIUD group, data was insignificant in all outcomes except bleeding. Conclusions: Post-placental insertion of IUD during a cesarean section appears to be a more effective and convenient method of contraception compared to delayed insertion of an IUD. This study showed that post-placental IUD insertion is associated with lower rates of expulsion, thread visibility and menorrhagia compared to delayed insertion.","PeriodicalId":8803,"journal":{"name":"Benha Veterinary Medical Journal","volume":"90 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135805629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-10-11DOI: 10.21608/bmfj.2023.230958.1881
Ashraf Elmantwea, Aziza Negm, Yehia Edris
{"title":"Retrospective Comparison of Non-descent Vaginal Hysterectomy and Total Laparoscopic Hysterectomy for Bulky Uterine Fibroids","authors":"Ashraf Elmantwea, Aziza Negm, Yehia Edris","doi":"10.21608/bmfj.2023.230958.1881","DOIUrl":"https://doi.org/10.21608/bmfj.2023.230958.1881","url":null,"abstract":"","PeriodicalId":8803,"journal":{"name":"Benha Veterinary Medical Journal","volume":"27 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136213543","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-10-11DOI: 10.21608/bmfj.2023.196558.1768
Azza Abd El-Khalek, Mohamed Farag, Khaled Salama, Ali Bendary, Rania Abd El-Aty
Background: The potential hazards of the COVID-19 coronavirus illness have prompted considerable caution. Pregnant women's clinical, radiological, and neonatal data can reveal serious issues such as pneumonia. Aim and objectives: to assess third-trimester COVID-19-infected mothers' and third-trimester babies' outcomes by comparing COVID-19-infected pregnant women to those without infection. Subjects and methods: One hundred pregnant women were split into two groups for this prospective observational study at Benha University Hospitals' obstetrics and gynecology department: Group (A) (Case Group): involved 50 pregnant women with a confirmed diagnosis of COVID-19; Group (B) (Control Group): included 50 normal pregnant women without a confirmed COVID-19 infection for at least 3 months. Result : There was a significant difference regarding maternal outcomes in both study groups. Conclusion: There is insufficient evidence to conclude that SARS-CoV-2 infection boosts the chances of maternal complications and fetal and neonatal problems. However, in this study, we found that difficult breast feeding and NICU admission were increasing in patients with COVID-19, which suggests the need for investigation of cystosis, lymph node enlargement, WBCs, and CRP to lower the risk of adverse outcomes.
{"title":"MATERNAL AND PERINATAL OUTCOME OF PREGNANT WOMEN WITH PCR CONFIRMED COVID-19 INFECTION IN THIRD TRIMESTER AND ITS EFFECT ON IUGR AND NEONATAL OUTCOME","authors":"Azza Abd El-Khalek, Mohamed Farag, Khaled Salama, Ali Bendary, Rania Abd El-Aty","doi":"10.21608/bmfj.2023.196558.1768","DOIUrl":"https://doi.org/10.21608/bmfj.2023.196558.1768","url":null,"abstract":"Background: The potential hazards of the COVID-19 coronavirus illness have prompted considerable caution. Pregnant women's clinical, radiological, and neonatal data can reveal serious issues such as pneumonia. Aim and objectives: to assess third-trimester COVID-19-infected mothers' and third-trimester babies' outcomes by comparing COVID-19-infected pregnant women to those without infection. Subjects and methods: One hundred pregnant women were split into two groups for this prospective observational study at Benha University Hospitals' obstetrics and gynecology department: Group (A) (Case Group): involved 50 pregnant women with a confirmed diagnosis of COVID-19; Group (B) (Control Group): included 50 normal pregnant women without a confirmed COVID-19 infection for at least 3 months. Result : There was a significant difference regarding maternal outcomes in both study groups. Conclusion: There is insufficient evidence to conclude that SARS-CoV-2 infection boosts the chances of maternal complications and fetal and neonatal problems. However, in this study, we found that difficult breast feeding and NICU admission were increasing in patients with COVID-19, which suggests the need for investigation of cystosis, lymph node enlargement, WBCs, and CRP to lower the risk of adverse outcomes.","PeriodicalId":8803,"journal":{"name":"Benha Veterinary Medical Journal","volume":"19 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136213113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-10-02DOI: 10.21608/bmfj.2023.218914.1843
Mostafa Zahran, Khaled El Rabat, Yaser Abd El Rahman, Ashraf Abd El Mageed, Amr El Nagar
Background: Access-site bleeding is the most frequent bleeding complication of transfemoral primary percutaneous coronary intervention (TF-PPCI). In contrast, transradial PPCI (TR-PPCI) has been demonstrated in multiple trials to be safer than the femoral approach due to the lower risk of significant bleeding. This study's objective was to study adoption of TR-PPCI for STEMI and its association with door‐to‐balloon time (D2BT). Methods: This study was carried out on 70 patients diagnosed as STEMI treated with PPCI were compared according to the access site used during the procedure. Patients were divided into 2 equal groups, group I: STEMI patients treated with TR-PPCI, and group II: STEMI patients treated with TF-PPCI. Patients were subjected to physical examination, risk assessment, electrocardiogram (ECG), transthoracic echocardiography, and coronary angioplasty. Results: D2BT was 107 min in TF-PPCI compared to 114 min in TF-PPCI group with no statistically significant difference. BMI and presence of prior peripheral arterial disease were significantly higher in TR-PPCI group compared to TF-PPCI group. Presence of cardiogenic shock and cardiac arrest within prior 24 h, and mean contrast volume were significantly lower in TR-PPCI group compared to TF-PPCI group ( p ≤ 0.05). Clinical data, ECG, laboratory data, patients’ presenting location, time in minutes, procedural medications, angiographic data, thrombus aspiration device, balloon angioplasty, direct stenting, number and type of stents, TIMI pre and post, and complications were insignificantly different between the studied groups. Conclusions: TR-PPCI can be successfully implemented without compromising D2BT performance offering the potential to improve STEMI outcomes if widely embraced.
{"title":"Adoption of Transradial Primary Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction and Its Association with Door-To-Balloon Time","authors":"Mostafa Zahran, Khaled El Rabat, Yaser Abd El Rahman, Ashraf Abd El Mageed, Amr El Nagar","doi":"10.21608/bmfj.2023.218914.1843","DOIUrl":"https://doi.org/10.21608/bmfj.2023.218914.1843","url":null,"abstract":"Background: Access-site bleeding is the most frequent bleeding complication of transfemoral primary percutaneous coronary intervention (TF-PPCI). In contrast, transradial PPCI (TR-PPCI) has been demonstrated in multiple trials to be safer than the femoral approach due to the lower risk of significant bleeding. This study's objective was to study adoption of TR-PPCI for STEMI and its association with door‐to‐balloon time (D2BT). Methods: This study was carried out on 70 patients diagnosed as STEMI treated with PPCI were compared according to the access site used during the procedure. Patients were divided into 2 equal groups, group I: STEMI patients treated with TR-PPCI, and group II: STEMI patients treated with TF-PPCI. Patients were subjected to physical examination, risk assessment, electrocardiogram (ECG), transthoracic echocardiography, and coronary angioplasty. Results: D2BT was 107 min in TF-PPCI compared to 114 min in TF-PPCI group with no statistically significant difference. BMI and presence of prior peripheral arterial disease were significantly higher in TR-PPCI group compared to TF-PPCI group. Presence of cardiogenic shock and cardiac arrest within prior 24 h, and mean contrast volume were significantly lower in TR-PPCI group compared to TF-PPCI group ( p ≤ 0.05). Clinical data, ECG, laboratory data, patients’ presenting location, time in minutes, procedural medications, angiographic data, thrombus aspiration device, balloon angioplasty, direct stenting, number and type of stents, TIMI pre and post, and complications were insignificantly different between the studied groups. Conclusions: TR-PPCI can be successfully implemented without compromising D2BT performance offering the potential to improve STEMI outcomes if widely embraced.","PeriodicalId":8803,"journal":{"name":"Benha Veterinary Medical Journal","volume":"3 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135901896","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-10-02DOI: 10.21608/bmfj.2023.216159.1836
Hager Allam, Khaled El-Din, Mohammed Hamouda, Hassan Almekawy
{"title":"Role of urinary fractional excretion of sodium in resistant hypertension patients","authors":"Hager Allam, Khaled El-Din, Mohammed Hamouda, Hassan Almekawy","doi":"10.21608/bmfj.2023.216159.1836","DOIUrl":"https://doi.org/10.21608/bmfj.2023.216159.1836","url":null,"abstract":"","PeriodicalId":8803,"journal":{"name":"Benha Veterinary Medical Journal","volume":"3 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135901921","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-10-02DOI: 10.21608/bmfj.2023.212836.1826
Fatma Abd-El-Fatah, Ahmad Abd-Elhamid, Alyaa Mahfouz, Emad Rezk
Background: Despite advances in therapy, sepsis is the leading cause of death in critical care settings, so early diagnosis of sepsis is a must, so we performed a meta-analysis to compare the accuracy of presepsin versus CRP and procalcitonin as biomarker of sepsis. Methods: This analysis performed using MEDLINE, EMBASE, PubMed and Cochrane to identify all published randomized, and prospective clinical trials, comparing the accuracy of Presepsin versus Procalcitonin and CRP in diagnosis of sepsis. Results: The Database of our meta-analysis included 13 studies with 2679 participants meeting definitive criteria of sepsis, The pooled sensitivity and of presepsin, procalcitonin and CRP was 0.84, 0.80, 0.69 respectively which shows that presepsin is stronger than procalcitonin and CRP, the pooled specificity of presepsin, procalcitonin, CRP was 0.73, 0.69, 0.68 respectively. The PLR and NLR of presepsin were 2.7 and 0.2, respectively and of procalcitonin were 2.6 and 0.29, respectively and of CRP were 2.6 and 0.41, respectively. The DOR of presepsin, procalcitonin and CRP was 11.8, 8.8, 6.2, respectively. Conclusions: This study demonstrated that presepsin is a reliable biomarker of sepsis because of its higher sensitivity and specificity than procalcitonin and CRP.
{"title":"Presepsin Versus CRP and Procalcitonin as Biomarker of Sepsis: A meta-analysis","authors":"Fatma Abd-El-Fatah, Ahmad Abd-Elhamid, Alyaa Mahfouz, Emad Rezk","doi":"10.21608/bmfj.2023.212836.1826","DOIUrl":"https://doi.org/10.21608/bmfj.2023.212836.1826","url":null,"abstract":"Background: Despite advances in therapy, sepsis is the leading cause of death in critical care settings, so early diagnosis of sepsis is a must, so we performed a meta-analysis to compare the accuracy of presepsin versus CRP and procalcitonin as biomarker of sepsis. Methods: This analysis performed using MEDLINE, EMBASE, PubMed and Cochrane to identify all published randomized, and prospective clinical trials, comparing the accuracy of Presepsin versus Procalcitonin and CRP in diagnosis of sepsis. Results: The Database of our meta-analysis included 13 studies with 2679 participants meeting definitive criteria of sepsis, The pooled sensitivity and of presepsin, procalcitonin and CRP was 0.84, 0.80, 0.69 respectively which shows that presepsin is stronger than procalcitonin and CRP, the pooled specificity of presepsin, procalcitonin, CRP was 0.73, 0.69, 0.68 respectively. The PLR and NLR of presepsin were 2.7 and 0.2, respectively and of procalcitonin were 2.6 and 0.29, respectively and of CRP were 2.6 and 0.41, respectively. The DOR of presepsin, procalcitonin and CRP was 11.8, 8.8, 6.2, respectively. Conclusions: This study demonstrated that presepsin is a reliable biomarker of sepsis because of its higher sensitivity and specificity than procalcitonin and CRP.","PeriodicalId":8803,"journal":{"name":"Benha Veterinary Medical Journal","volume":"14 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135901923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-10-02DOI: 10.21608/bmfj.2023.214627.1831
Al Shimaa M. Sabry, Osama S. Arafa, Mohammed A. Barakat, Mohamed M. Ali
Background: CHA2DS2-VASc score is used to predict the risk of thrombo-embolic events in patients with AF. In this study, CHA2DS2-VASc score was investigated to show its correlation with TIMI flow count among patients with ST elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI). Patients & Methods: A total number 106 patients with STEMI were included in this study. Patients were divided into two groups as control group (TIMI III flow) (n= 69) and no-reflow group (n= 37). CHA2DS2-VASc score was calculated and a cut off value of >2 was used as a predictor of TIMI flow count. Results: The no-reflow patients were significantly older with higher prevalence of DM and HTN. Multivariate regression analysis showed that CHA2DS2-VASc score is a significant independent predictor of the no-reflow. Conclusions: CHA2DS2-VASc score is as an easy, fast and independent predictor of TIMI flow count after primary PCI.
{"title":"CHA2DS2 VASc score and its correlation with TIMI flow count in patients with STEMI Undergoing primary PCI","authors":"Al Shimaa M. Sabry, Osama S. Arafa, Mohammed A. Barakat, Mohamed M. Ali","doi":"10.21608/bmfj.2023.214627.1831","DOIUrl":"https://doi.org/10.21608/bmfj.2023.214627.1831","url":null,"abstract":"Background: CHA2DS2-VASc score is used to predict the risk of thrombo-embolic events in patients with AF. In this study, CHA2DS2-VASc score was investigated to show its correlation with TIMI flow count among patients with ST elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI). Patients & Methods: A total number 106 patients with STEMI were included in this study. Patients were divided into two groups as control group (TIMI III flow) (n= 69) and no-reflow group (n= 37). CHA2DS2-VASc score was calculated and a cut off value of >2 was used as a predictor of TIMI flow count. Results: The no-reflow patients were significantly older with higher prevalence of DM and HTN. Multivariate regression analysis showed that CHA2DS2-VASc score is a significant independent predictor of the no-reflow. Conclusions: CHA2DS2-VASc score is as an easy, fast and independent predictor of TIMI flow count after primary PCI.","PeriodicalId":8803,"journal":{"name":"Benha Veterinary Medical Journal","volume":"59 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135901925","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Role of Fetuin-A as a Noninvasive Biomarker in Diagnosis and Assessment of Severity of Non-Alcoholic Fatty Liver Disease.","authors":"Badawy Abdulaziz, Mohamed abd elhamid, Mohamed Elhoseeny, Haitham Mostafa, Radwa Elsharaby, Ghadeer Rashad","doi":"10.21608/bmfj.2023.226193.1869","DOIUrl":"https://doi.org/10.21608/bmfj.2023.226193.1869","url":null,"abstract":"","PeriodicalId":8803,"journal":{"name":"Benha Veterinary Medical Journal","volume":"3 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135901926","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：